Title | Type | SJR | H index | Total Docs. (2005) | Total Docs. (3years) | Total Refs. (2005) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2005) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Cardiovascular Drugs and Therapy | journal | 0.738 Q2 | 79 | 59 | 202 | 1845 | 410 | 172 | 1.65 | 31.27 | |
52 | Trials | journal | 0.730 Q2 | 98 | 18 | 24 | 763 | 36 | 24 | 0.93 | 42.39 | |
53 | Neurotherapeutics | journal | 0.712 Q2 | 136 | 58 | 51 | 5904 | 131 | 45 | 2.57 | 101.79 | |
54 | Psychopharmacology Bulletin | journal | 0.707 Q2 | 66 | 0 | 108 | 0 | 271 | 106 | 2.48 | 0.00 | |
55 | British Journal of Clinical Pharmacology, Supplement | journal | 0.706 Q2 | 33 | 0 | 27 | 0 | 110 | 25 | 3.56 | 0.00 | |
56 | Clinical Neuropharmacology | journal | 0.703 Q2 | 85 | 71 | 191 | 2008 | 484 | 174 | 2.54 | 28.28 | |
57 | Annals of Pharmacotherapy | journal | 0.702 Q2 | 122 | 391 | 1139 | 9356 | 2447 | 888 | 2.11 | 23.93 | |
58 | BMC Pharmacology | journal | 0.670 Q2 | 48 | 17 | 69 | 548 | 136 | 69 | 1.77 | 32.24 | |
59 | Reading Teacher | journal | 0.662 Q2 | 60 | 68 | 250 | 1645 | 138 | 246 | 0.49 | 24.19 | |
60 | International Journal of STD and AIDS | journal | 0.661 Q2 | 78 | 240 | 642 | 3638 | 777 | 513 | 1.08 | 15.16 | |
61 | American Journal of Cardiovascular Drugs | journal | 0.657 Q2 | 60 | 40 | 143 | 3146 | 282 | 133 | 1.94 | 78.65 | |
62 | Current Treatment Options in Oncology | journal | 0.654 Q2 | 66 | 46 | 151 | 2402 | 317 | 151 | 2.15 | 52.22 | |
63 | BioDrugs | journal | 0.649 Q2 | 79 | 35 | 137 | 3137 | 357 | 133 | 2.30 | 89.63 | |
64 | International Journal of Clinical Pharmacology and Therapeutics | journal | 0.647 Q2 | 73 | 97 | 296 | 1840 | 567 | 280 | 1.93 | 18.97 | |
65 | Human Psychopharmacology | journal | 0.646 Q2 | 86 | 69 | 240 | 2281 | 502 | 221 | 1.98 | 33.06 | |
66 | Paediatric Drugs | journal | 0.620 Q2 | 70 | 32 | 180 | 3071 | 474 | 171 | 2.69 | 95.97 | |
67 | Expert Opinion on Drug Safety | journal | 0.616 Q2 | 90 | 93 | 149 | 7544 | 341 | 145 | 2.04 | 81.12 | |
68 | American Journal of Therapeutics | journal | 0.604 Q2 | 69 | 89 | 236 | 3158 | 491 | 211 | 1.84 | 35.48 | |
69 | Expert Opinion on Pharmacotherapy | journal | 0.595 Q2 | 93 | 242 | 594 | 16676 | 1479 | 582 | 2.47 | 68.91 | |
70 | Pulmonary Pharmacology and Therapeutics | journal | 0.590 Q2 | 81 | 54 | 189 | 2167 | 422 | 185 | 1.96 | 40.13 | |
71 | Journal of Infection and Chemotherapy | journal | 0.588 Q2 | 72 | 63 | 216 | 1207 | 309 | 206 | 1.46 | 19.16 | |
72 | Fundamental and Clinical Pharmacology | journal | 0.586 Q2 | 85 | 77 | 213 | 3234 | 456 | 211 | 2.17 | 42.00 | |
73 | Expert Review of Anticancer Therapy | journal | 0.583 Q2 | 85 | 108 | 323 | 7186 | 530 | 288 | 1.81 | 66.54 | |
74 | Expert Opinion on Emerging Drugs | journal | 0.570 Q2 | 54 | 53 | 88 | 6214 | 194 | 86 | 2.83 | 117.25 | |
75 | Journal of Population Therapeutics and Clinical Pharmacology (discontinued) | journal | 0.567 Q2 | 45 | 23 | 81 | 526 | 96 | 71 | 1.34 | 22.87 | |
76 | Journal of Biopharmaceutical Statistics | journal | 0.556 Q2 | 56 | 70 | 162 | 1150 | 153 | 157 | 0.94 | 16.43 | |
77 | Chemotherapy | journal | 0.555 Q2 | 61 | 96 | 167 | 2812 | 309 | 160 | 1.69 | 29.29 | |
78 | Journal of Ocular Pharmacology and Therapeutics | journal | 0.554 Q2 | 72 | 58 | 173 | 1688 | 208 | 172 | 1.14 | 29.10 | |
79 | Breast Cancer | journal | 0.536 Q2 | 66 | 100 | 192 | 5884 | 257 | 187 | 1.24 | 58.84 | |
80 | Drugs of Today | journal | 0.517 Q2 | 57 | 76 | 243 | 4444 | 469 | 242 | 1.98 | 58.47 | |
81 | Current Neuropharmacology | journal | 0.505 Q2 | 103 | 23 | 32 | 3390 | 42 | 30 | 1.31 | 147.39 | |
82 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.488 Q2 | 81 | 87 | 208 | 2151 | 335 | 197 | 1.52 | 24.72 | |
83 | Acta Pharmacologica Sinica | journal | 0.468 Q2 | 117 | 221 | 693 | 6998 | 1006 | 692 | 1.53 | 31.67 | |
84 | International Journal of Clinical Pharmacy | journal | 0.455 Q2 | 71 | 97 | 175 | 1986 | 198 | 154 | 1.13 | 20.47 | |
85 | Journal of Supportive Oncology | journal | 0.447 Q2 | 65 | 127 | 148 | 1424 | 176 | 83 | 1.19 | 11.21 | |
86 | American Journal Geriatric Pharmacotherapy | journal | 0.438 Q2 | 63 | 41 | 50 | 1278 | 62 | 40 | 1.24 | 31.17 | |
87 | Drug Metabolism and Pharmacokinetics | journal | 0.434 Q2 | 75 | 57 | 169 | 945 | 239 | 169 | 1.52 | 16.58 | |
88 | Biopharmaceutics and Drug Disposition | journal | 0.403 Q2 | 65 | 51 | 136 | 1173 | 191 | 136 | 1.33 | 23.00 | |
89 | Drugs under Experimental and Clinical Research | journal | 0.403 Q2 | 41 | 36 | 102 | 879 | 156 | 102 | 1.43 | 24.42 | |
90 | European Journal of Contraception and Reproductive Health Care | journal | 0.403 Q2 | 53 | 46 | 115 | 983 | 121 | 115 | 1.11 | 21.37 | |
91 | Journal of Chemotherapy | journal | 0.401 Q2 | 56 | 115 | 399 | 3127 | 518 | 365 | 1.20 | 27.19 | |
92 | Pharmaceutical Statistics | journal | 0.391 Q2 | 46 | 31 | 32 | 410 | 23 | 28 | 0.72 | 13.23 | |
93 | Medical Letter on Drugs and Therapeutics | journal | 0.369 Q2 | 22 | 66 | 188 | 569 | 145 | 188 | 0.91 | 8.62 | |
94 | Primary Care - Clinics in Office Practice | journal | 0.356 Q2 | 59 | 59 | 169 | 3218 | 178 | 156 | 0.91 | 54.54 | |
95 | Advances in Antiviral Drug Design | book series | 0.347 Q2 | 12 | 0 | 7 | 0 | 6 | 7 | 0.86 | 0.00 | |
96 | Drug Metabolism and Personalized Therapy | journal | 0.338 Q3 | 38 | 12 | 38 | 269 | 49 | 38 | 1.07 | 22.42 | |
97 | International Journal of Clinical Pharmacology Research | journal | 0.319 Q3 | 32 | 25 | 51 | 624 | 75 | 51 | 1.46 | 24.96 | |
98 | Drug and Therapeutics Bulletin | journal | 0.317 Q3 | 17 | 28 | 97 | 745 | 63 | 93 | 0.76 | 26.61 | |
99 | HeartDrug | journal | 0.281 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
100 | Drugs of the Future | journal | 0.278 Q3 | 46 | 612 | 797 | 5933 | 277 | 319 | 0.23 | 9.69 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®